ENT Hand Instrument Market Size, Share, & COVID-19 Impact Analysis - Global - 2023-2029 - MedCore - Includes: Sinus Hand Instruments, Laryngeal Hand Instruments, and 1 more
The global market for ENT hand instruments had a valuation of $133.9 million in 2022. According to projections, it will grow at a Compound Annual Growth Rate (CAGR) of 1.5% during the forecast period and reach $148.8 million. The market comprises sinus, laryngeal, and otological hand instruments, and the complete report suite covers these product categories.
MARKET DATA INCLUDED
Unit Sales, Average Selling Prices, Market Size & Growth Trends
Procedure Numbers
COVID-19 Impact Analysis
Market Drivers & Limiters
Market Forecasts Until 2029, and Historical Data to 2019
Recent Mergers & Acquisitions
Company Profiles and Product Portfolios
Leading Competitors
GLOBAL ENT HAND INSTRUMENT MARKET INSIGHTS
The familiarity of physicians with ENT hand instruments is a significant market driver. Over the years of practice, physicians have become accustomed to these devices, which have many similarities with other general instruments like forceps. This familiarity makes it more comfortable for physicians to use ENT hand instruments.
GLOBAL ENT HAND INSTRUMENT MARKET SHARE INSIGHTS
The Global ENT hand instrument market was led by Karl Storz, Olympus, and Integra Lifesciences.
In 2022, Karl Storz was the top competitor in the global market for ENT hand instruments. The company has a robust product portfolio, with hand instruments available in every segment of the market. However, Karl Storz has a particularly dominant position within the laryngeal instrument segment. To provide added value to its customers, the company frequently bundles its instrument kits with rigid scopes, thereby offering a one-stop-shop solution for its clients.
MARKET SEGMENTATION SUMMARY
ENT Hand Instrument Market – MedCore – Includes:
Sinus, Laryngeal, and Otological hand instruments.
RESEARCH SCOPE SUMMARY
Regions : North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
Base Year: 2022
Forecast Period: 2023-2029
Historical Data: 2019-2022
Quantitative Data: Market Size, Market Share, Market Growth Rates, Units Sold, Average Selling Prices
Qualitative Data: COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios
Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data.
WHY CHOOSE IDATA?
Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.
Pricing – When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook